ABSTRACT RNA has been isolated from a human pancreatic somatostatinoma and used to prepare a cDNA library. After prescreening, clones containing somatostatin I sequences were identified by hybridization with an anglerfish somatostatin I-cloned cDNA probe. From the nucleotide sequence oftwo ofthese clones, we have deduced an essentially full-length mRNA sequence, including the preprosomatostatin coding region, 105 nucleotides from the 5' untranslated region and the complete 150-nucleotide 3' untranslated region. The coding region predicts a 116-amino acid precursor protein (Mr, 12, 727) that contains somatostatin-14 and -28 at its COOH terminus. The predicted amino acid sequence of human somatostatin-28 is identical to that of somatostatin-28 isolated from the porcine and ovine species. A comparison of the amino acid sequences ofhuman and anglerfish preprosomatostatin I indicated that the COOH-terminal region encoding somatostatin-14 and the adjacent 6 amino acids are highly conserved, whereas the remainder of the molecule, including the signal peptide region, is more divergent. However, many of the amino acid differences found in the pro region of the human and anglerfish proteins are conservative changes. This suggests that the propeptides have a similar secondary structure, which in turn may imply a biological function for this region of the molecule.
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Somatostatin is a 14-amino acid polypeptide that inhibits the secretion of other polypeptides and hormones, including growth hormone, insulin, glucagon, and gastrin (reviewed in ref. 1) . It occurs in the pancreas, stomach, and small intestine, as well as in the central nervous system. Its presence in neuronal tissue (2) and its apparent neurophysiological action (3) has led to the postulate that somatostatin is also a neurotransmitter.
Higher Mr forms of somatostatin immunoreactivity have been detected (4) . Studies (5) ofthe biosynthesis ofsomatostatin in cultured rat pancreatic islets have suggested that the larger immunoreactive species are somatostatin precursors. A 28-amino acid peptide containing the somatostatin moiety has been isolated from porcine intestine (6) and hypothalamus (7) and more recently from ovine hypothalamus (8) .
We recently have cloned and sequenced somatostatin cDNA from the endocrine pancreas of anglerfish (9) . The nucleotide sequence of the coding region predicted a 121-amino acid polypeptide containing somatostatin at its COOH terminus. This polypeptide is presumed to be the first somatostatin precursor. We also discovered another cDNA from anglerfish that encoded a 125-amino acid polypeptide that contained a somatostatin-like moiety at its COOH terminus. This somatostatin differs from the former somatostatin in two of the 14 amino acids (Tyr in place of Phe-7 and Gly in place of Thr-10). Therefore, we termed the classical somatostatin sequence somatostatin I and the novel sequence somatostatin II. Somatostatin II has been chemically synthesized and shown to inhibit selectively insulin release with no detectable effect on glucagon release. Thus, the activity is qualitatively different from somatostatin I. This justifies the assertion that these represent two functional forms of the hormone (unpublished observations). Subsequently, others have demonstrated the presence of two somatostatin forms in catfish (10) (11) (12) .
This report describes the cloning and sequence determination of a cDNA coding for human preprosomatostatin I. As yet we have been unable to detect cDNA sequences coding for a sanatostatin II. The predicted amino acid sequence of the putative somatostatin precursor contains-segments; identical to those of somatostatin-14 and somatostatin-28, which have been isolated from pig and sheep, suggesting that these molecules are derived from a common precursor. We also have compared the amino acid sequence derived from human and anglerfish preprosomatostatin I. An analysis of the conserved structures provides evidence of functional regions in the molecule.
MATERIALS AND METHODS
cDNA Synthesis and Construction of Recombinant Plasmids. Thirty milligrams of human pancreatic somatostatinoma tissue embedded for freeze sectioning, provided by D. M. McCarthy, was cleaned of its embedding compound, lyophilized, and then homogenized in 6 ml of 4 M guanidine thiocyanate (13) . The RNA was sedimented through a CsCl cushion (14) , extracted with phenol/chloroform, and precipitated with ethanol. The total yield of RNA was 480 mg. The first-strand cDNA was synthesized in a reaction mixture (150 ml) containing 25 mg of RNA, 10 mM Tris chloride (pH 8.3), 70 mM KCI, 8 mM MgCl2, 0.05% 2-mercaptoethanol, 1 mM dGTP, dCTP, and dTTP, 0.5 mM dATP, 40 units of reverse transcriptase (RNA-dependent DNA nucleotidyltransferase; J. Beard, National Cancer Institute), and 100 ,uCi (1 Ci = 3.7 X 1010 becquerels) of [a-32P]dATP. After 30 min at 43°C, the RNA was basehydrolyzed, and the first-strand cDNA molecules were tailed with 30 dC residues by using terminal deoxynucleotidyltransferase. The second strand was synthesized as described by Cooke et aL (15) except that DNA polymerase I replaced reverse transcriptase for extension of the oligo(dG) primer (Collaborative Research). Approximately 70 ng of dC-tailed doublestranded cDNA was hybridized with an equimolar portion of pBR322 that had been tailed with dG in the Pst I site. The resulting hybrid plasmids were used to transform Escherichia coli strain HB101 in compliance with the National Institutes of Health guidelines (P3/HV1).
Library Screening. Tetracycline-resistant transformants grown on Whatman 541 paper were screened by using probes comprising either the first-strand cDNA prepared from tumor RNA (specific activity, 5 x 108 cpm/liter per mg) or a nick-translated insert derived from cloned anglerfish or human preprosomatostatin cDNA. The hybridizations were carried out at 68°C for Proc. Nati Acad. Sci. USA 79 (1982) 20 hr in 0.75 M NaCV0.075 M Na citrate, pH 7/0.1 M sodium phosphate, pH 7/0.1% polyvinylpyrrolidone/0. 1% Ficoll/1% bovine serum albumin in the presence of sonicated, denatured salmon sperm DNA (100 tkg/ml) and labeled DNA (105 cpm/ ml). The filters were washed twice with 0.3 M NaCV0.03 M Na citrate, pH 7/0.1% NaDodSO4 at room temperature for 30 min with continual agitation, followed by two 15-min washes in 0.015 M NaCl/0.0015 M Na citrate, pH 7/0.1% NaDodSO4 at 50'C. For conditions of lower stringency, the latter washing step was eliminated. Hybridizing colonies were identified by autoradiography for 20 hr at -70'C with a single Dupont Lightning Plus intensifying screen.
Characterization of Recombinants. The size of the recombinant plasmid was estimated as follows: a portion ofthe colony was removed, and the cells were lysed; the DNA was electrophoresed in 1% agarose gel and transferred to nitrocellulose filters. The hybridization and washing conditions used were as described above.
The sequence of the cDNA inserts was determined by the procedure of Maxam and Gilbert (16) with the G+A modification of Cooke et aL (17) .
RESULTS
Cloning and Identification of Somatostatin cDNA. Total RNA was isolated from a portion of a human pancreatic somatostatinoma that contained 100 times as much somatostatin immunoreactivity as a normal pancreas contains (18) . A cDNA library was constructed in the Pst I site of pBR322, and 933 tetracycline-resistant, ampicillin-sensitive colonies were obtained. Assuming that somatostatin mRNA was an abundant species in the somatostatinoma, we screened for cDNA clones derived from frequent mRNAs by in situ hybridization with [32P]cDNA prepared from the tumor RNA; 71 such colonies were identified, but these did not give detectable cross-hybridization with anglerfish somatostatin I or II [32P]cDNA probes. To provide a more sensitive test for hybridization, DNAs prepared from the 71 recombinants were electrophoresed and bound to nitrocellulose filters, which were incubated with the two anglerfish somatostatin cDNA probes and then washed under conditions of low hybridization stringency. Seventeen recombinants now hybridized with the anglerfish somatostatin I cDNA probe; none hybridized with the somatostatin II probe. Two recombinant plasmids, pHSl-68 (283 base pairs) and pHS8-90 (382 base pairs), were shown by DNA sequence analysis to contain a segment encoding somatostatin. Sequence of Human Somatostatin I cDNA. The general strategy of sequence determination used for pHS8-86 and pHS3-16 is indicated in Fig. 1 . All restriction enzyme sites used to initiate the determination were confirmed by assaying the sequence through them from adjacent sites. In this instance, it was important to determine the sequence of both strands because several sequence compression artifacts were observed. The sequence was checked against portions of sequence determined from four additional independently isolated clones. By this method, the entire sequence was confirmed except for the first two 5' and the last 11 3' nucleotides, which are absent from the four extra clones. Further, comparison of the partial restriction maps of 17 of the larger recombinants revealed no sequence heterogeneity.
The 603 nucleotides of human preprosomatostatin I mRNA sequence derived from the two clones is shown in Fig. 2 , along with the predicted amino acid sequence of the somatostatin precursor; the size is shown in Fig. 3 Proc. Natl. Acad. Sci. USA 79 (1982) the sequence of somatostatin-14 at its COOH terminus. The predicted sequence agrees precisely with the known sequence of somatostatin-14 isolated from other mammals. Human preprosomatostatin I, like other secretory proteins, presumably contains a signal (pre-) peptide that targets the molecule for secretion. We have tentatively identified residues -102 to -79 as the signal peptide on the basis of structural similarities with other signal peptides. This leaves a pro region of 92 amino acids beginning with alanine -78. The general organization of the human preprosomatostatin I molecule (summarized in Fig.  2 ) is essentially the same as that previously described for the precursors for somatostatin I and II from anglerfish (9). Somatostatin-28 (which contains somatostatin-14 at its COOH terminus) has been described in porcine (6, 7) and ovine (8) 
